ISRCTN69541857
Completed
N/A
Effect of botulinum toxin A injections and specific intensive rehabilitation therapy in children with hemiparetic cerebral palsy on upper limb functions and skills
Ipsen Biopharm Ltd (UK)0 sites60 target enrollmentMarch 31, 2008
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ipsen Biopharm Ltd (UK)
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged 2\.5 \- 12 years, either sex
- •2\. Cerebral palsy
- •3\. Hagberg diagnosis: spastic hemiparesis or extreme asymmetric diplegia
- •4\. Hand function impairment Zancolli grade I with evident problems in thumb extension and supination, Zancolli grade IIA and IIB
- •5\. Mentally able to comprehend and perform tasks
- •6\. Children and their parents should be able to cope with the intensive rehabilitation therapy programme and the measurement sessions
- •7\. Children and the parents/caregivers should comprehend and speak Dutch
- •8\. Children and their parents indicate the necessity for improvement of the children's abilities
Exclusion Criteria
- •1\. Severe structural contractures of the muscles at the extremity to be treated:
- •1\.1\. Passive elbow extension maximum 160 degrees or less
- •1\.2\. Supination maximum 30 degrees or less from neutral position
- •1\.3\. Wrist dorsal flexion maximum 20 degrees or less in children aged 2\.5 \- 6 years, or 45 degrees or less in age group 7 \- 12 years
- •2\. Severe impairment of hand function: no active hand function is expected after treatment (Zancolli III)
- •3\. Hand surgery or phenolisation or btA injections in the arm less than nine months ago
- •4\. Contraindication for botulinum toxin (muscular diseases such as myasthenia gravis, tetanus vaccination less than three months before the injection, use of aminoglycoside antibiotics or spectinomycine and known hypersensitivity for human albumin)
- •5\. Contraindication for anaesthesia
- •6\. Children who cannot bear touching the affected arm and hand
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
N/A
Effect of Botulinum Toxin A Injections and Specific Intensive Rehabilitation Therapy in Children with Hemiparetic Cerebral Palsy on Upper Limb Functions and Skills - BoBiVa (Botuline toxine Bimanuele Vaardigheden)Study design: a factorial design with four study groups in which btA alone, intensive rehabilitation therapy aimed at improving bimanual skills alone, a combination of these two and continuing the regular therapy program will be compared to each other.Study population: children with CP, spastic hemiparesis, aged 2.5 – 12 years.EUCTR2006-002175-40-NL60
Completed
Phase 3
Effect of Botulinum Toxin A Injections and Specific Intensive Rehabilitation Therapy in Children with Hemiparetic Cerebral Palsy on Upper Limb Functions and Skillscongenital hemiparesisSpastic hemiparetic cerebral palsy10010335NL-OMON30186Hoensbroek Revalidatiecentrum (HRC)60
Completed
Phase 2
botulinum toxin type A and diabetic neuropathyDiabeticr polyneuropathy.Type 2 diabetes mellitus with diabetic polyneuropathyE10.42IRCT20190129042540N1Rafsanjan University of Medical Sciences50
Active, Not Recruiting
N/A
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with a stiff knee gait. - Botulinum toxin type A injections in stiff knee gaitStroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients.EUCTR2009-018226-29-NL26
Completed
Phase 3
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gaitstiff knee gaitstiff-legged knee1000796310057166NL-OMON39359Revalidatiecentrum Het Roessingh26